Should the CD4 threshold for starting ART be raised?

The Lancet

Volumn 373, Issue 9672, 2009, Pages 1314-1316

  Wood, Robin ^a   Lawn, Stephen D ^a,b  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANTIBIOTIC THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL DECISION MAKING; DRUG SAFETY; HEALTH CARE ACCESS; HUMAN IMMUNODEFICIENCY VIRUS; KIDNEY DISEASE; LIVER DISEASE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 64649085336     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60654-1     Document Type: Note

References (12)

1. Lane H.C., and Neaton J.D. When to start therapy for HIV infection: a swinging pendulum in search of data. Ann Intern Med 138 (2003) 680-681
2. Schechter M. Therapy for early HIV infection: how far back should the pendulum swing?. J Infect Dis 190 (2004) 1043-1045
3. Holmberg S.D., Palella Jr. F.J., Lichtenstein K.A., and Havlir D.V. The case for earlier treatment of HIV infection. Clin Infect Dis 39 (2004) 1699-1704
4. Ho D.D. Time to hit HIV, early and hard. N Engl J Med 333 (1995) 450-451
5. Gazzard B.G. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 9 (2008) 563-608
6. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents (Nov 3, 2008). http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed March 18, 2009).
7. When to Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 10.1016/S0140-6736(09)60612-7 published online April 9.
8. Emery S., Neuhaus J.A., Phillips A.N., et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 197 (2008) 1133-1144
9. National Institute of Allergy and Infectious Diseases. Effectiveness of immediate and deferred antiretroviral treatment in HIV-infected adults (March 20, 2009). http://clinicaltrials.gov/ct2/show/NCT00821171?term=START&cond=HIV &intr=antiretroviral&rank=2 (accessed March 18, 2009).
10. Badri M., Lawn S.D., and Wood R. Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. Lancet 368 (2006) 1254-1259
11. Lawn S.D., Harries A.D., Anglaret X., Myer L., and Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22 (2008) 1897-1908
12. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006). http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf (accessed March 18, 2009).